Skip to main content
. 2022 Sep 20;10:1018399. doi: 10.3389/fpubh.2022.1018399

Figure 1.

Figure 1

Comorbidities observed in the patient cohort. (A) Frequencies of comorbidities reported in the cohort. (B) Percentages of each comorbidities and in combinations. Footnotes: Nil, patients with no comorbid conditions; DM, diabetes mellitus; HTN, hypertension; CVD, cardiovascular disease (includes coronary artery disease, ischemic heart disease); CVA, cerebrovascular accident (stroke); RD, rheumatic disease (includes rheumatic arthritis, rheumatic heart disease); COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; CLD, chronic liver disease; others, includes hypothyroidism, (n = 7), malignancies (n = 4), pulmonary tuberculosis (n = 4), Parkinson's disease (n = 3), seizure disorder (n = 2), anemia (n = 3); psychiatric disorders (n = 2), and biliary atresia (n = 1).